XLON:NFX

Newfield Exploration Company Stock Insider Trading

London Stock Exchange > Healthcare > Biotechnology

Open Broker Account

£0.190

+0 (+0%)

At Close: Apr 30, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About Newfield Exploration Company

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. Its lead programs include NXP001, which is in Phase 1-ready stage for oncology supportive care; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. The company is also developing NXP004, which is in the research Phase for treating oncology. It also has an optio... NFX.L Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Newfield Exploration Company Stock Insider Trading

About Newfield Exploration Company

Golden Star

Top Fintech Company